GlassScriptPhysician profile
Kenneth K Kim
NPI 1952473274
$1,780.09
in general payments reported to CMS, 2019-2025
10 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $50.94 · 2021: $371 · 2022: $405 · 2023: $156 · 2024: $370 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $551.45 | 2019-2022 | |
| Allergan, INC. | $441.41 | 2019-2022 | |
| Polynovo North America LLC | $168.15 | 2024 | Novosorb Btm |
| Abbvie INC. | $136.00 | 2025 | |
| Motiva USA, LLC | $125.00 | 2025 | |
| Solventum Corporation | $120.17 | 2024 | V.A.C. Simplace, Prevena |
| Mentor Worldwide LLC | $115.91 | 2023 | Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $68.39 | 2024 | Artiss |
| Musculoskeletal Transplant Foundation INC. | $39.87 | 2023 | |
| Galderma Laboratories, L.P. | $13.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.